Squibb

The drugs—Yervoy from Bristol-Myers Squibb Co., and vemurafenib from Roche Holding AG and Daiichi Sankyo Co.—use sharply different methods of treating the disease.

Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011

Harnessing the immune system's powers as a cancer weapon has long been a goal of researchers, and two immunotherapies developed from different approaches— Dendreon Corp.'s prostate cancer treatment Provenge and Bristol-Myers Squibb Co.'s melanoma drug Yervoy—have recently reached the market.

Gene Treatment Offers Hope in Leukemia Cases Ron Winslow 2011

Since May 2004, Pfizer, Eli Lilly, Bristol-Myers Squibb and four other drug companies have paid a total of $7 billion in fines and penalties.

Beyond the Underground: 2010

Although not early-stage drugs, Bristol-Myers Squibb Co. and Roche Holding AG made a splash last week by signing a collaboration agreement to test a combination of two melanoma treatments.

Cancer-Drug Alliances Expected to Increase Thomas Gryta 2011

Bristol-Myers Squibb A combination of two melanoma drugs—Bristol-Myers' Yervoy and a new BRAF inhibitor drug from Roche—is being tested as a possible treatment for the cancer.

Cancer-Drug Alliances Expected to Increase Thomas Gryta 2011

Plavix, co-marketed by Sanofi-Aventis SA and Bristol-Myers Squibb Co., is widely prescribed along with aspirin to prevent blood clots in patients treated with devices called stents that prop open diseased coronary arteries.

Worries About Using Plavix With Heartburn Pills May Be Overblown Ron Winslow 2010

U.S. investigators are looking at ways that several drug makers — including Merck, AstraZeneca, Bristol-Myers Squibb and GlaxoSmithKline — could be paying bribes overseas to boost sales and speed approvals, according to letters sent to the firms and people close to the matter.

Business Watch 2010

In 1997 when Bristol-Myers Squibb Co. decided to end its efforts in the field, Mr. Siegall and another former Bristol-Myers scientist formed Seattle Genetics with technology they licensed from their former company.

Novel Cancer Drug Shows Promise Thomas Gryta 2010

AstraZeneca PLC, Bristol-Myers Squibb Co. and GlaxoSmithKline PLC — in recent months have disclosed they are being investigated for possible violations of a 1977 law that makes it illegal for companies whose stock is traded in the U.S. to bribe government officials in other countries to get business.

Drug Firms Face Bribery Probe Michael Rothfeld 2010

It also works with many of the world's biggest healthcare companies, including Pfizer , Bristol-Myers Squibb , Roche Holding AG, Novartis , Eli Lilly and Baxter International Inc. For many of these companies, DKSH is both selling their products in Asian markets and procuring highly-specialized raw materials for production elsewhere.

Look Beyond China, Says DKSH's CEO Anita Greil 2011